Latest News about CRSP
Recent news which mentions CRSP
Why a Biotech ETF Might Cure Your Portfolio in 2023
December 07, 2022
From ETF Trends
3 Fierce Stocks That Are Screaming Buys in December
December 07, 2022
From Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
December 06, 2022
From Motley Fool
Bear Market Bargain Hunting: 3 Top Stocks to Buy Before 2023
December 06, 2022
From Motley Fool
3 Growth Stocks That Are Too Cheap to Ignore
December 01, 2022
From Motley Fool
2 Stocks Near 52-Week Highs That Could Climb Higher
November 28, 2022
From Motley Fool
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
November 25, 2022
From Motley Fool
What 5 Analyst Ratings Have To Say About CRISPR Therapeutics
November 23, 2022
Tickers
CRSP
From Benzinga
From Benzinga
Where Will Editas Medicine Be in 1 Year?
November 20, 2022
From Motley Fool
2 Growth Stocks That Could Double in 2023
November 17, 2022
From Motley Fool
Crispr Therapeutics Stock: Bull vs. Bear
November 15, 2022
From Motley Fool
5 Top Stocks to Buy Before 2023
November 15, 2022
From Motley Fool
Vertex Pharmaceuticals: Buy at the High?
November 14, 2022
From Motley Fool
Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait a Decade
November 12, 2022
From Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
November 10, 2022
From Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
November 09, 2022
Tickers
CRSP
From Benzinga
3 Healthcare Stocks That Could Go Parabolic
November 09, 2022
From Motley Fool
Why Shares of CRISPR Therapeutics Dropped 19.9% in October
November 07, 2022
Tickers
CRSP
From Motley Fool
Got $1,000? 2 Smart Stocks to Consider Buying Right Now
November 06, 2022
From Motley Fool
2 Biotech Stocks That Could Make You Richer
November 04, 2022
From Motley Fool
3 Top Healthcare Stocks to Buy for November
November 04, 2022
From Motley Fool
What 8 Analyst Ratings Have To Say About CRISPR Therapeutics
November 02, 2022
Tickers
CRSP
From Benzinga
Better Buy: CRISPR Therapeutics vs. Bluebird Bio
October 27, 2022
From Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
October 26, 2022
From Motley Fool
Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
October 24, 2022
Tickers
CRSP
From Benzinga
The Top 5 Stocks Cathie Wood Bought and Sold This Week
October 21, 2022
From InvestorPlace
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.